Increased circulating monocyte count is related to good collateral development in coronary artery disease

Sinan Altan Kocaman1, Uğur Arslan, Yusuf Tavil

  • 1Gazi University School of Medicine, Department of Cardiology, Besevler, 06500 Ankara, Turkey. sinanaltan@gmail.com

Atherosclerosis
|August 21, 2007
PubMed

Insights

Higher circulating monocyte counts are linked to better coronary collateral development in patients with severe coronary artery disease (CAD). This finding may improve understanding of cardiovascular medicine.

Area of Science:

  • Cardiology
  • Immunology
  • Vascular Biology

Background:

  • Monocytes play a key role in collateral growth, as shown in animal models.
  • Collateral circulation is crucial for supplying blood to ischemic tissues in coronary artery disease (CAD).

Purpose of the Study:

  • To investigate the association between circulating monocyte count and collateral development in patients with severely stenotic CAD.
  • To determine if monocyte levels can predict collateralization in CAD patients.

Main Methods:

  • Analysis of coronary angiograms from 210 patients with >=95% stenosis in a major coronary artery.
  • Classification of collateral development as good (103 patients) or poor (107 patients) using the Cohen-Rentrop method.
  • Multivariate analysis to compare monocyte counts between the two groups.

Main Results:

  • A significantly higher monocyte count was observed in patients with good collateral development (671+/-218 mm(-3)) compared to those with poor collateral development (522+/-195 mm(-3), p<0.001).
  • Increased monocyte count was independently associated with good collateral development (Odds Ratio [OR], 2.918; 95% Confidence Interval [CI], 1.281-6.648; p=0.011).

Conclusions:

  • Circulating monocyte count is a significant predictor of collateral development in patients with severe CAD.
  • This finding highlights the clinical and basic importance of monocytes in cardiovascular medicine and collateralization.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...